The significant increase in workload of drug safety employees has triggered a virtual explosion of new digital systems for drug safety and pharmacovigilance. With a vendor agnostic approach, NNIT can help you navigate safely and select the best solution for your specific needs.
Across the life sciences industry, pharmacovigilance (PV) inboxes are groaning under a steadily growing volume of adverse event reports, greatly adding to the workload of the drug safety employees. Fortunately, there is no shortage of digital systems that can potentially make the PV processes much more manageable and efficient. However, this variety of choice brings its own form of complexity.
At NNIT, we have guided life sciences through digital transformation for decades. In recent years, we have seen a significantly increased focus on drug safety and pharmacovigilance, and the market for solutions towards this area is much more diverse than for instance regulatory affairs or clinical.
As many pharma companies have discovered, finding, and implementing the right PV system can be challenging. This hurdle can be overcome with the help of a trusted advisor like NNIT, who has both the industry insights and technical expertise to guide you safely both before and after go-live.
In-house or outsourced
Some pharma companies choose to outsource most of their PV activities to a contract research organization (CRO) or similar third-party partner. But a significant portion choose to manage PV themselves because they want to maintain the full overview and control, and ensure that drug safety serves as a business accelerator.
With the right mindset and tools, a life sciences organization can transform drug safety from a cost center to a value-creating part of the business. The insights from PV data can be used to drive significant improvements in business outcomes. But regardless of whether this task is outsourced or kept in-house, you need a strong digital data foundation to do it.